Ministry of Health, Labour and Welfare (MHLW)
Japan's regulatory ministry overseeing cosmetics under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. Japan classifies products as 'cosmetics' or 'quasi-drugs,' each with distinct regulatory pathways.
The Ministry of Health, Labour and Welfare (MHLW) is the Japanese government ministry responsible for healthcare, labour, and welfare policy. Through its Pharmaceutical and Food Safety Bureau, MHLW regulates cosmetics and quasi-drugs under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (commonly called the PMD Act or Pharmaceutical Affairs Law).
Japan uses a dual classification system: "cosmetics" (keshouhin) are products with mild effects on the body, while "quasi-drugs" (iyaku bugaihin) are products with moderate pharmacological effects — including sunscreens, hair growth products, antiperspirants, and medicated cosmetics. Quasi-drugs require MHLW approval before marketing.
For cosmetics, Japan maintains a positive list of approved ingredients (Comprehensive Licensing Standards). Any ingredient not on the positive list requires a specific ingredient approval application. For quasi-drugs, each product must receive manufacturing and marketing approval from MHLW.
Imported cosmetics require a Marketing Authorization Holder (MAH) licensed in Japan who takes responsibility for the product's quality and safety. Japanese labeling requirements include full ingredient listing, product name, MAH name and address, and country of origin.
Related Terms
International Nomenclature of Cosmetic Ingredients (INCI)
A standardized system of ingredient naming developed by the Personal Care Products Council (formerly CTFA), used worldwide for cosmetic ingredient labeling. INCI names are required on product labels in the EU, US, Canada, and most other regulated markets.
ProcessGood Manufacturing Practices (GMP)
A system of guidelines ensuring cosmetic products are consistently produced and controlled according to quality standards. MoCRA requires FDA to establish cosmetic GMP regulations; in the EU, compliance with ISO 22716 is presumed to satisfy the GMP requirement of EC 1223/2009.
See how Cosmetica automates compliance
Replace manual regulatory work with AI-powered automation — from ingredient screening to submission filing.
